Portal Innovations — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management.
AI & Machine LearningDigital HealthMedical DevicesChicago, US
Amit K. Gupta(Executive Officer, Director)Omer Tolga Inan(Director)Andrew Michael Carek(Executive Officer)Omer Inan(Co-founder, Chief Scientific Officer)Andrew Carek(Co-founder, Chief Technical Officer)Amit Gupta(Co-founder, Advisor (former founding CEO))
Co-investorsBayMed Venture PartnersBroadview VenturesCross-Border Impact VenturesLaerdal Million Lives FundOSF VenturesHatteras Venture Partners
ClostraBio develops next-generation probiotics and a platform for delivering bacterial metabolites to support gut health, targeting inflammatory bowel disease (IBD) and food allergy.
BiotechDigital HealthHealthtechChicago, US
Jeffrey Hubbell(Secretary)Cathryn Nagler(President)Brett Newswanger(Chief Operating Officer)
BoardJohn Flavin(Executive Chairman)
Co-investorsStone Mountain Ventures
Vivtex is a drug development company applying computational science and pre-clinical research to advance new medicines.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
GIOVANNI TRAVERSO(Director)THOMAS VON ERLACH(Executive Officer, Director)Thomas von Erlach(CEO & Co-founder)JAMES WINSCHEL(Executive Officer, Director)JUAN LOPEZ(Executive Officer)ROBERT LANGER(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.